Remarkable recent advances have revolutionized the field of heart failure. Survival has
improved among individuals with heart failure and a reduced ejection fraction and for the …

Heart failure with preserved ejection fraction (HFpEF) accounts for nearly half of all heart
failure cases and has a prevalence that is expected to rise with the growing ageing …

Aims Although body mass index (BMI) is the most commonly used anthropometric measure,
newer indices such as the waist-to-height ratio, better reflect the location and amount of …

Importance A genetic variant in theTTRgene (rs76992529; Val122Ile), present more
commonly in individuals with African ancestry (population frequency: 3%-4%), causes …

Background. We sought to measure the levels of adipokines, TNF-α and soluble receptors
(sTNFr1, sTNFr2) in heart failure patients with reduced ejection fraction (HFrEF) due to non …

Obesity with increased high-sensitive cardiac troponin T (hs-cTnT) has been reported to be
more likely to progress cardiovascular disease (CVD) events, which suggests that hs-cTnT …

Background N-terminal pro-B-type natriuretic peptide (NT-proBNP) is a biomarker used for
the diagnosis of heart failure. There is a relationship between NT-proBNP levels and body …

Natriuretic peptides (NP) play an essential role in heart failure (HF) regulation, and their
measurement has improved diagnostic and prognostic accuracy. Clinical symptoms and …

Background The relationship of serial NT‐proBNP (N‐terminal pro‐B‐type natriuretic
peptide) measurements with changes in cardiac features and outcomes in heart failure (HF) …

The diagnosis of heart failure (HF) primarily relies on signs and symptoms that are neither
sensitive nor specific. This impedes timely diagnosis and delays effective therapies or …